Patent · US Active

Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof

US8207299B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignee

BIOMERIEUX, INC. · FR

Inventors

Guy Serre · Toulouse, FR
Mireille Sebbag · Toulouse, FR

Key dates

Filing date	Nov 3, 2005
Grant date	Jun 26, 2012
Priority date	—
Expiry date	Oct 30, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/75
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates to novel citrulline peptides derived from fibrin α and β chains which are recognizable by specific citrulline antiprotein autoantibodies (AAPC) of a rheumatoid arthritis (PR) and to the use thereof for detecting the presence of said specific PR AAPC in a biological sample.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.